bisoprolol has been researched along with Bleeding in 2 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Excerpt | Relevance | Reference |
---|---|---|
" Since telmisartan is an inhibitor of P-glycoprotein (P-gp), the elimination of rivaroxaban and apixaban, which are substrates of P-gp, is hindered, resulting in increased blood levels of both drugs, thereby increasing the risk of hemorrhage." | 4.02 | Comprehensive Exploration of Medications That Affect the Bleeding Risk of Oral Anticoagulant Users. ( Akagi, Y; Aoyama, T; Enomoto, A; Hoshiko, M; Kawano, Y; Kujirai, A; Mano, Y; Nagata, M; Nakamatsu, S; Nakamura, S; Negishi, K; Nishikawa, T; Shimada, S; Suzuki, T; Tsukada, E, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Skalias, A | 1 |
Karamitsou, P | 1 |
Mitos, G | 1 |
Zarzava, E | 1 |
Tsapara, V | 1 |
Poutoglidis, A | 1 |
Gougousis, S | 1 |
Kawano, Y | 1 |
Nagata, M | 1 |
Nakamura, S | 1 |
Akagi, Y | 1 |
Suzuki, T | 1 |
Tsukada, E | 1 |
Hoshiko, M | 1 |
Kujirai, A | 1 |
Nakamatsu, S | 1 |
Nishikawa, T | 1 |
Enomoto, A | 1 |
Negishi, K | 1 |
Shimada, S | 1 |
Aoyama, T | 1 |
Mano, Y | 1 |
1 trial available for bisoprolol and Bleeding
Article | Year |
---|---|
Does preoperative administration of hypotensive agents affect the quality of the surgical field during endoscopic sinus surgery? A triple-blind randomized controlled trial.
Topics: Bisoprolol; Blood Loss, Surgical; Endoscopy; Hemorrhage; Humans; Nifedipine; Prospective Studies; Si | 2023 |
1 other study available for bisoprolol and Bleeding
Article | Year |
---|---|
Comprehensive Exploration of Medications That Affect the Bleeding Risk of Oral Anticoagulant Users.
Topics: Administration, Oral; Administrative Claims, Healthcare; Amlodipine; Anticoagulants; Antihypertensiv | 2021 |